| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 828.36B | 832.75B | 837.84B | 766.02B | 735.62B | 680.96B |
| Gross Profit | 79.52B | 83.80B | 78.92B | 69.29B | 62.88B | 57.37B |
| EBITDA | 30.08B | 30.42B | 30.19B | 24.83B | 23.78B | 23.07B |
| Net Income | 19.51B | 20.63B | 19.83B | 20.00B | 19.48B | 22.35B |
Balance Sheet | ||||||
| Total Assets | 448.41B | 498.14B | 441.97B | 427.32B | 380.44B | 389.06B |
| Cash, Cash Equivalents and Short-Term Investments | 59.56B | 76.84B | 59.84B | 51.37B | 36.35B | 35.40B |
| Total Debt | 81.14B | 89.84B | 75.46B | 64.72B | 66.76B | 66.22B |
| Total Liabilities | 232.65B | 252.20B | 225.41B | 220.56B | 198.93B | 212.14B |
| Stockholders Equity | 206.98B | 235.78B | 208.16B | 200.17B | 179.46B | 174.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.90B | 16.12B | 27.59B | 7.39B | -13.12B |
| Operating Cash Flow | 0.00 | 21.07B | 19.90B | 30.19B | 9.91B | -11.45B |
| Investing Cash Flow | 0.00 | -13.01B | -9.50B | -1.39B | 8.28B | 5.45B |
| Financing Cash Flow | 0.00 | 3.92B | -805.00M | -14.98B | -17.57B | 6.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥543.60B | 15.11 | 6.52% | 1.82% | 4.95% | 52.94% | |
73 Outperform | ¥327.64B | 9.57 | 5.47% | 3.41% | 0.55% | 25.37% | |
69 Neutral | ¥195.62B | 10.26 | ― | 3.43% | -0.61% | 5.77% | |
64 Neutral | ¥437.97B | 4.51 | 8.14% | 2.61% | -0.45% | 50.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥796.81B | 20.28 | 2.01% | 3.82% | -7.76% | 7.92% | |
58 Neutral | ¥964.93B | -17.36 | -2.50% | 3.49% | -4.57% | -190.44% |